Rational design and synthesis of topoisomerase I and II inhibitors based on oleanolic acid moiety for new anti-cancer drugs

Bioorganic & Medicinal Chemistry
2014.0

Abstract

Semisynthetic reactions were conducted on oleanolic acid, a common plant-derived oleanane-type triterpene. Ten rationally designed derivatives of oleanolic acid were synthesized based on docking studies and tested for their topoisomerase I and IIα inhibitory activity. Semisynthetic reactions targeted C-3, C-12, C-13, and C-17. Nine of the synthesized compounds were identified as new compounds. The structures of these compounds were confirmed by spectroscopic methods (1D, 2D NMR and MS). Five oleanolic acid analogues (S2, S3, S5, S7 and S9) showed higher activity than camptothecin (CPT) in the topoisomerase I DNA relaxation assay. Four oleanolic acid analogues (S2, S3, S5 and S6) showed higher activity than etoposide in a topoisomerase II assay. The results indicated that the C12-C13 double bond of the oleanolic acid skeleton is important for the inhibitory activity against both types of topoisomerases, while insertion of a longer chain at either position 3 or 17 increases the activity against topoisomerases by various degrees. Some of the synthesized compounds act as dual inhibitors for both topoisomerase I and IIα.

Knowledge Graph

Similar Paper

Rational design and synthesis of topoisomerase I and II inhibitors based on oleanolic acid moiety for new anti-cancer drugs
Bioorganic & Medicinal Chemistry 2014.0
Rational Design and Semisynthesis of Betulinic Acid Analogues as Potent Topoisomerase Inhibitors
Journal of Natural Products 2009.0
Synthesis and topoisomerase II inhibitory and cytotoxic activity of oxiranylmethoxy- and thiiranylmethoxy-chalcone derivatives
Bioorganic & Medicinal Chemistry Letters 2011.0
Synthesis and topoisomerases inhibitory activity of heteroaromatic chalcones
Bioorganic & Medicinal Chemistry 2016.0
Design, synthesis and biological evaluation of 3-arylisoquinoline derivatives as topoisomerase I and II dual inhibitors for the therapy of liver cancer
European Journal of Medicinal Chemistry 2022.0
Synthesis and biological evaluation of C1- O -substituted-3-(3-butylamino-2-hydroxy-propoxy)-xanthen-9-one as topoisomerase IIα catalytic inhibitors
European Journal of Medicinal Chemistry 2016.0
Synthesis and cytotoxicity evaluation of oleanolic acid derivatives
Bioorganic & Medicinal Chemistry Letters 2013.0
Novel securinine derivatives as topoisomerase I based antitumor agents
European Journal of Medicinal Chemistry 2016.0
Synthesis of rotenoid derivatives with cytotoxic and topoisomerase II inhibitory activities
Bioorganic & Medicinal Chemistry Letters 2011.0
One pot synthesis, in silico study and evaluation of some novel flavonoids as potent topoisomerase II inhibitors
Bioorganic & Medicinal Chemistry Letters 2021.0